Literature DB >> 12803390

Infection by Parvicapsula sp. (Myxozoa) is associated with mortality in sea-caged Atlantic salmon Salmo salar in northern Norway.

Erik Sterud1, Pernilla Simolin, Agnar Kvellestad.   

Abstract

In March 2002, 3 seawater farms in northern Norway experienced high mortality among Atlantic salmon postsmolts. A myxosporean parasite assigned to the genus Parvicapsula was detected in the pseudobranchs of diseased fish, and extensive destruction of this organ was observed. The parasite was also found in the gills, liver and kidney of some fish. Based on host species, spore morphology, and the unusual site preference of the parasite, it is likely that it represents a hitherto undescribed species. The diseased fish had been transferred to seawater in September 2001, and it is believed that the infection took place shortly after exposure to seawater. The source of infection is unknown.

Entities:  

Mesh:

Year:  2003        PMID: 12803390     DOI: 10.3354/dao054259

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  3 in total

1.  Seatrout (Salmo trutta) is a natural host for Parvicapsula pseudobranchicola (Myxozoa, Myxosporea), an important pathogen of farmed Atlantic salmon (Salmo salar).

Authors:  Haakon Hansen; Trygve T Poppe; Turhan Markussen; Egil Karlsbakk
Journal:  Parasit Vectors       Date:  2015-04-10       Impact factor: 3.876

2.  Detection of the myxosporean parasite Parvicapsula pseudobranchicola in Atlantic salmon (Salmo salar L.) using in situ hybridization (ISH).

Authors:  Turhan Markussen; Celia Agusti; Egil Karlsbakk; Are Nylund; Øyvind Brevik; Haakon Hansen
Journal:  Parasit Vectors       Date:  2015-02-15       Impact factor: 3.876

3.  Infection dynamics and tissue tropism of Parvicapsula pseudobranchicola (Myxozoa: Myxosporea) in farmed Atlantic salmon (Salmo salar).

Authors:  Are Nylund; Haakon Hansen; Øyvind J Brevik; Håvard Hustoft; Turhan Markussen; Heidrun Plarre; Egil Karlsbakk
Journal:  Parasit Vectors       Date:  2018-01-06       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.